Ultragenyx Pharmaceutical, Inc. (RARE)
35.98
-0.32
(-0.87%)
USD |
NASDAQ |
Dec 10, 16:00
35.98
0.00 (0.00%)
After-Hours: 17:54
Ultragenyx Pharmaceutical Profit Margin (Quarterly): -112.8% for Sept. 30, 2025
Profit Margin (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Profit Margin Definition
Profit Margin is calculated using Net Income/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into profit. An analyst looking at profit margin might look for a higher profit margin relative to other comparable companies as well as a profit margin that is growing.
Profit Margin (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Profit Margin (Quarterly) Benchmarks
| Regeneron Pharmaceuticals, Inc. | 38.89% |
| Amicus Therapeutics, Inc. | 10.24% |
| Geron Corp. | -39.02% |
| Ionis Pharmaceuticals, Inc. | -82.06% |
| Vertex Pharmaceuticals, Inc. | 34.76% |
Profit Margin (Quarterly) Related Metrics
| Return on Equity | -307.8% |
| Return on Assets | -42.32% |
| Return on Invested Capital | -53.69% |
| Gross Profit Margin (Quarterly) | 77.12% |
| Operating Margin (Quarterly) | -106.9% |
| Return on Net Operating Assets | -90.48% |